Click Therapeutics Anticipates Pharma Will Begin Developing Digital Drugs From Clinical Stage

FDA Draft Guidance And Exploding GLP-1 R&D Create New Horizons For Digital Therapeutics

Leading digital therapeutic maker’s CEO David Benshoof Klein and CMO Shaheen Lakhan discuss outlook on the DTx space, priorities going forward, and what makes Click a standout player in a changing game.

Medtech On The Brain
• Source: Shutterstock

[Editor's note: This article appeared first in HBW Insight's sister publication Medtech Insight.]

Draft guidance issued last year by the US Food and Drug Administration and the GLP-1 agonist drug boom are among...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Digital Technologies

More from HBW Insight